Ads Focused On a Few Drug Risks Might Make Them Memorable

NPR - Steven Woloshin and Lisa Schwartz are quoted extensively on the Food and Drug Administration's call for research into how prescription drug ads can be improved. Schwartz's research on two new weight-loss drugs with harmful side effects is also discussed. Schwartz and Woloshin are both professors of medicine and of community and family medicine, as well as co-directors of the Medicine and the Media program. This story was published by NPR's Shots. Read more...